About OcuRes Consult

OcuRes Consult is founded on over 15 years of PhD-level experience in biomedical sciences and preclinical research. It merges extensive translational expertise with a strong focus on ophthalmology. Programs developed under this knowledge have successfully progressed from early discovery through preclinical drug development and into Phase 2 clinical trials.  

OcuRes Consult supports various biotech companies, academic groups, and CRO partners in navigating (ophthalmic) preclinical drug development, regulatory alignment, and investor-facing requirements—bridging the gap between scientific innovation and successful clinical progression.

If you’re interested in collaborating or require support with your (ophthalmic) preclinical programs, please feel free to reach out.